Virginie Bondu Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

4/2023	Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression.
1/2023	The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.
1/2021	MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginie Bondu Research Topics

Disease

7	Infections 04/2023 - 10/2017
4	Neoplasms (Cancer) 04/2023 - 01/2021
3	Papillomavirus Infections 01/2023 - 01/2021
2	COVID-19 10/2021 - 07/2021
1	Carcinogenesis 01/2023
1	Virus Diseases (Viral Diseases) 01/2022
1	Inflammation (Inflammations) 01/2018
1	Hantavirus Infections 10/2017

Drug/Important Bio-Agent (IBA)

4	IntegrinsIBA 10/2021 - 10/2017
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2023 - 01/2021
2	VaccinesIBA 04/2023 - 01/2023
2	Antiviral Agents (Antivirals)IBA 04/2023 - 01/2023
2	rhodamine BIBA 10/2021 - 07/2021
2	TalinIBA 10/2021 - 07/2021
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2017
2	Peptides (Polypeptides)IBA 10/2021 - 07/2021
1	trametinibIBA 04/2023
1	Protamines (Protamine Sulfate)FDA Link 01/2022
1	Anti-Infective Agents (Microbicides)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 10/2021
1	o-PhthalaldehydeIBA 01/2021
1	Viral ProteinsIBA 01/2021
1	Disinfectants (Biocides)IBA 01/2021
1	AldehydesIBA 01/2021
1	antimycinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Thromboplastin (Tissue Factor)IBA 01/2018
1	CoagulantsIBA 01/2018
1	Plasminogen Activator Inhibitor 1IBA 01/2018
1	Purinergic P2Y2 ReceptorsIBA 01/2018

Therapy/Procedure

2	Therapeutics 04/2023 - 01/2023